HIGH-DENSITY LIPOPROTEIN (HDL) - ANVISA Registration 10303460492

Access comprehensive regulatory information for HIGH-DENSITY LIPOPROTEIN (HDL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10303460492 and manufactured by IN VITRO DIAGNOSTICA LTDA. The registration is held by IN VITRO DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including LABTEST DIAGNOSTICA S/A, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10303460492
Registration Details
ANVISA Registration Number: 10303460492
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família HDL Direto Liquicolor
Risk Class II

Registration Details

10303460492

25351445260201970

42837716000198

Company Information

Brazil
PT: BRASIL

Dates and Status

Nov 04, 2019

VIGENTE

09/18/2025 19:00:01